Next Article in Journal
Ultrasound-Promoted One-Pot, Four-Component Synthesis of Pyridin-2(1H)-One Derivatives
Previous Article in Journal
Three New Ursane-Type Triterpenoids from the Stems of Saprosma merrillii
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Facile Creation of 3-Substituted-3-Hydroxy-2-Oxindoles by Arginine-Catalyzed Aldol Reactions of α,β-Unsaturated Ketones with Isatins

1
State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China
2
Analytical & Testing Center, Sichuan University, Chengdu 610064, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2013, 18(12), 14505-14518; https://doi.org/10.3390/molecules181214505
Submission received: 14 October 2013 / Revised: 15 November 2013 / Accepted: 19 November 2013 / Published: 25 November 2013

Abstract

:
An efficient approach for the synthesis of 3-substituted-3-hydroxy-2-oxindoles has been achieved via an aldol reaction of α,β-unsaturated ketones and isatins using arginine as an organocatalyst. A range of 3-substituted-3-hydroxy-2-oxindoles were obtained in moderate to high (up to 99%) yields. These 3-substituted-3-hydroxy-2-oxindoles with an additional enone moiety provide an opportunity for further elaboration of the products and for potentially interesting biological activities. In addition, the formation of 3-substituted-3-hydroxy-2-oxindole 3a was confirmed by X-ray crystallography. The possible reaction mechanism reveals that the reaction proceeds via a double action process.

Graphical Abstract

1. Introduction

3-Substituted-3-hydroxy-2-oxindoles are heterocyclic organic compounds that possess a carbonyl group at the 2-position of the 5-membered ring and a quaternary carbon centre at the 3-position of this ring. This kind of compounds have become important synthetic targets as these structural frameworks form the core units of many natural products and pharmaceutically active compounds [1]. Convolutamydines [2], arundaphine [3], donaxaridine [4], dioxibrassinine [5], maremycins [6], paratunamide [7], celogentin K [8], TMC-95A-D [9], flustraminol [10], 3-hydroxy welwitindolinones [11] and CPC-1 [12] are some examples of a growing list of bioactive 3-substituted-3-hydroxy-2-oxindole natural products (Figure 1).
Figure 1. Biologically important molecules containing 3-substituted-3-hydroxy-2-oxindoles.
Figure 1. Biologically important molecules containing 3-substituted-3-hydroxy-2-oxindoles.
Molecules 18 14505 g001
They display diverse biological and pharmacological activities such as potent antioxidant, anticancer, anti-HIV, and neuroprotective properties. Owing to the significance of this structural motif, numerous elegant synthetic methodologies have been developed [13,14,15,16,17,18,19,20,21] and aim to facilitate the synthesis of sufficient quantities of the desired natural products and related analogues for biological evaluation and structure-activity relationship studies, and thus finally contribute to the development of new therapeutic agents or important biological tools. The most direct approach to 3-substituted-3-hydroxy oxindoles is a nucleophilic addition of appropriate nucleophiles to isatins, such as the aldol reaction or an alkylation of isatins. Recently, several elegant approaches to 3-aryl or alkyl-3-hydroxyindolin-2-ones via the cross-aldol reaction between isatins and ketones have been extensively studied [22,23,24,25,26,27,28,29,30,31]. However, few examples of the corresponding aldol reactions of various α,β-unsaturated ketones with isatins were found in the literature. The aldol addition of an α,β-unsaturated ketone to isatin could produce 3-substituted-3-hydroxy-2-oxindoles with an additional enone moiety and thus provide a chance for further elaboration of the products (Scheme 1) and perhaps different or improved biological activities [30,31]. The formation of quaternary carbon centers and the chemoselectivity (α,β-unsaturated ketone as a nucleophile is arising from the inherent multiple reactivity that involve ketone, β-carbon and methylene unit) via addition of α,β-unsaturated ketones to isatins represents a major challenge and has stimulated many a synthetic chemist.
Scheme 1. Further elaboration of 3-hydroxy-3-(2-oxo-4-arylbut-3-enyl) indolin-2-one products.
Scheme 1. Further elaboration of 3-hydroxy-3-(2-oxo-4-arylbut-3-enyl) indolin-2-one products.
Molecules 18 14505 g003
α-Amino acids are readily available organic molecules, which have so far been utilized as chiral auxiliaries, chiral ligands and chiral synthons for natural products and drugs. Using amino acids as a catalyst over other organic molecules could provide considerable green technology benefits because amino acids are a component of natural proteins and completely biodegradable in nature [32,33,34,35]. Since List, Lerner, and Barbas first reported the proline-catalyzed direct aldol reaction [36], other amino-acid based organocatalysts have been developed as mimics of enzymes for various reactions. The mechanism in the proline-mediated reactions is based on the initial formation of an imine between the nitrogen atom of proline and the carbonyl group of the substrate and then conversion to an enamine [37]. Such an imine can be formed by other amino acids and thus the other amino acids could catalyze similar reactions. In view of this mechanism, we wish to further extend the use of amino acids as organocatalysts. Herein, we describe the use of amino acids for the facile synthesis of 3-substituted-3-hydroxy-2-oxindole frameworks in high yields (up to 99%) via the aldol reactions of α,β-unsaturated ketones and isatins (Scheme 2).
Scheme 2. Synthesis of 3-substituted-3-hydroxy-2-oxindoles.
Scheme 2. Synthesis of 3-substituted-3-hydroxy-2-oxindoles.
Molecules 18 14505 g004

2. Results and Discussion

In our initial studies, the direct aldol reaction between isatin (1a) as an acceptor and (E)-4-phenylbut-3-en-2-one (2a) as a donor with a catalyst loading of 20 mol% in MeOH at room temperature was selected as a benchmark for catalyst evaluation. Some screening results are listed in Table 1. The simple amino acids bearing only an amino group and a carboxyl group could not catalyze this reaction. No expected aldol adducts were observed after direct determination by TLC (Table 1, entries 1–5). This indicated that it is impossible for the aldol reaction in which these primary amine and secondary amine catalysts unilaterally activate the (E)-4-phenylbut-3-en-2-one (2a) to form an enamine intermediate. Then, we turned our attention to other complex amino acids such as arginine, tryptophan and histidine as catalysts (Table 1, entries 6–8). Pleasingly, arginine, an amino acid skeleton with a guanidine group, was effective for the reaction, affording the desired product 3a in 88% yield (Table 1, entry 7). The formation of 3a was confirmed by X-ray crystallography (Figure 2) [38]. Although l-arginine was used as a catalyst, the product was obtained as a racemic mixture. The decrease of the reaction temperature down to 0 °C did not alter the enantioselectivity (data not shown).
Table 1. Catalyst screening and reaction conditions optimization a.
Table 1. Catalyst screening and reaction conditions optimization a.
EntryCatalystSolventTime/hYield (%) b
1ProlineMeOH24N.D c
2PhenylalanineMeOH24N.D
3LeucineMeOH24N.D
4TyrosineMeOH24N.D
5Tyrosine methyl esterMeOH24N.D
6HistidineMeOH24N.D
7ArginineMeOH2488
8TryptophanMeOH24N.D
9Boc-ArginineMeOH24N.D
10 dArginineMeOH2479
11 eArginineMeOH2491
12 fArginineMeOH2476
13 gArginineMeOH2444
14 e,hArginineMeOH1249
15 e,hArginineMeOH2452
16 eArginineMeOH1255
17 eArginineMeOH4898
a Unless indicated otherwise, the reaction was carried out in 0.1 mmol scale in solvent (1.0 mL) at 25 °C for 24 h, and the ratio of 1a/2a/catalyst is 1:1:0.2; b Isolated yield based on isatin; c N.D. refers to no reaction; d Catalyst loading is 5 mol%; e Catalyst loading is 10 mol%; f Catalyst loading is 30 mol%; g Catalyst loading is 50 mol%; h Temperature is 60 °C.
Figure 2. X-ray crystal structure of 3a.
Figure 2. X-ray crystal structure of 3a.
Molecules 18 14505 g002
To further improve the yields, efforts were made to optimize other reaction parameters including solvents, catalyst loading and reaction temperatures. Thus, the reaction was studied in different solvents that included CH2Cl2, THF, dioxane, CH3CN, toluene, EtOH, i-BuOH, n-BuOH and H2O, but no better result was obtained. In general, reactions carried out in protic solvents gave better yields than those in aprotic solvents. This may be caused by poor solubility of arginine in aprotic solvents and H2O. Catalyst loading influenced the rate of the reaction. As the catalyst loading increased to 10 mol %, the yield increased steadily (Table 1, entries 7, 10, 11). Further improvement, however, was not achieved by further increasing the catalyst loading (Table 1, entries 12, 13). Temperature also influenced the rate of the reaction. Elevating the reaction temperature resulted in a low yield, while conducting the reaction at 60 °C gave a certain amount of byproducts (Table 1, entries 14, 15). The relatively higher yield of reaction could be compensated by prolonging reaction time to 48 h, and up to 98% yield was obtained (Table 1, entry 17). Through extensive screening, the optimized catalytic system was found to be 1a/2a/arginine = 1/1/0.1, 1.0 mL MeOH as solvent at 25 °C for 48 h.
Having the optimized conditions in hand, the aldol reaction of α,β-unsaturated ketones with different structures was investigated. As shown in Table 2, a variety of α,β-unsaturated ketones proved to be excellent nucleophiles for this reaction, and provided the corresponding 3-substituted-3-hydroxy-2-oxindoles in good yields (up to 98%) (Table 2, entries 1–15). The electronic properties and steric hindrance of the substituents at the aromatic ring influenced the yields slightly. Generally, α,β-unsaturated ketones with electron-donating groups gave higher yields than those with electron-withdrawing groups (Table 2, entries 2, 10 vs. 3–8). Ortho- and meta-substituted α,β-unsaturated ketones gave higher yields than para-substituted α,β-unsaturated ketones (Table 2, entries 2‒5 vs. 8‒11). α,β-Unsaturated ketones bearing naphthyl and heterocyclic substituents participated in smooth aldol reactions in 81% and 88% yield, respectively (Table 2, entries 13, 14). Moreover, it is worthwhile to note that an α,β-unsaturated ketones derived from an aliphatic aldehyde was investigated and it was transformed with moderate yield (Table 2, entry 15). To further extend the application of arginine, substituted isatins with several representative α,β-unsaturated ketones were also examined (Table 2, entries 16–18). Incorporating protecting groups on the N1 of oxindole had no effect on reactivity, and gave the desired product in almost quantitative yield (99%) (Table 2, entry 16). However, the electronic properties of the substituents at the isatin affected the yields strongly (Table 2, entries 17–20). Isatin with an electron-donating group only gave 60% yield.
Table 2. Substrate scope for the aldol reaction of isatins and α,β-unsaturated ketones a. Molecules 18 14505 i001
Table 2. Substrate scope for the aldol reaction of isatins and α,β-unsaturated ketones a. Molecules 18 14505 i001
Entry123Yield (%) b
1R1 = R2 = R3 = R4 = HR5 = Ph3a98
2R1 = R2 = R3 = R4 = H R5 = 4-MeO-C6H43b95
3R1 = R2 = R3 = R4 = H R5 = 4-F-C6H43c87
4R1 = R2 = R3 = R4 = H R5 = 4-Cl-C6H43d80
5R1 = R2 = R3 = R4 = H R5 = 4-Br-C6H43e82
6R1 = R2 = R3 = R4 = H R5 = 4-NO2-C6H43f75
7R1 = R2 = R3 = R4 = H R5 = 3-CF3-C6H43g86
8R1 = R2 = R3 = R4 = H R5 = 3-Br-C6H43h85
9R1 = R2 = R3 = R4 = H R5 = 3-Cl-C6H43i82
10R1 = R2 = R3 = R4 = H R5 = 3-MeO-C6H43j96
11R1 = R2 = R3 = R4 = H R5 = 2-F-C6H43k92
12R1 = R2 = R3 = R4 = H R5 = 3,4-diCl-C6H43l73
13R1 = R2 = R3 = R4 = H R5 = 2-Naphthyl3m81
14R1 = R2 = R3 = R4 = H R5 = 2-Furyl3n88
15R1 = R2 = R3 = R4 = H R5 = Propyl3o67
16R1 = R2 = R3 = H, R4 = CH2PhR5 = Ph3p99
17R1 = Me, R2 = R3 = R4 = H R5 = Ph3q60
18R1 = Br, R2 = R3 = R4 = HR5 = Ph3r99
19R3 = Cl, R1 = R2 = R4 = HR5 = Ph3s93
20R2 = Cl, R1 = R3 = R4 = HR5 = Ph3t92
a The reaction was carried out in 0.1 mmol scale in MeOH (1.0 mL) at 25 °C for 48 h, and the ratio of 1/2/arginine is 1:1:0.1; b Isolated yield based on isatins.
Based on the results (Table 1, entries 1–9) and previous reports, [39,40,41] a possible reaction mechanism for the formation of 3-substituted-3-hydroxy-2-oxindoles could be proposed. As depicted in Scheme 3, in solid form or in polar solutions, amino acids can exist as zwitterions, which contain a protonated amino group and deprotonated carboxylate group. It is obvious that simple amino acids (only bearing an amine group and a carboxyl group) in zwitterionic form could not be considered as a base and therefore did not participate in this reaction (Table 1, entries 1–5). However, arginine, as a basic amino acid which possesses side chain basicity (pKa = 12.48) due to its guanidine group, can take a proton from the protonated amino group thereby resulting in the formation of the naked amino group.
Then, the naked amino group can also form an enamine with the carbonyl group of the substrate (Table 1, entries 7, 9) and the guanidine group presumably activates the carbonyl group of isatin (Table 1, entries 6–8). This double action of the amino acid may play a key role in this reaction and hence facilitate the aldol reaction.
Scheme 3. The double action catalysis mechanism.
Scheme 3. The double action catalysis mechanism.
Molecules 18 14505 g005

3. Experimental

3.1. General

All chemicals were obtained from commercial sources and used without further purification. Column chromatography was carried out on silica gel (300–400 mesh, Qingdao Marine Chemical Ltd., Qingdao, China). Thin layer chromatography (TLC) was performed on TLC silica gel 60 F254 plates. 1H-NMR spectra were recorded on a Bruker AVII-400 MHz NMR spectrometer. The chemical shifts were recorded in ppm relative to tetramethylsilane and with the solvent resonance as the internal standard. Data were reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartlet, m = multiplet), coupling constants (Hz), integration. 13C-NMR data were collected at 100 MHz with complete proton decoupling. Chemical shifts were reported in ppm from the tetramethylsilane with the solvent resonance as internal standard. MS spectra were obtained on a Waters Quattro Premier XETM triple quadrupole mass spectrometer and methanol was used to dissolve the sample. Melting points were recorded at SGW X-4 Melting point instrument (Shanghai Precision & Scientific Instrument Co., Ltd, Shanghai, China).

3.2. Experimental Procedures

A mixture of isatin 1a (0.1 mmol), (E)-4-phenylbut-3-en-2-one (2a, 0.1 mmol), arginine (0.01 mmol) in MeOH (1.0 mL) was stirred for 48 h at 25 °C. After completion of the reaction (TLC), the solvent was removed under vacuum. The crude product was subjected to column chromatography on silica gel using petroleum ether/ethyl acetate = 1:1 as the eluent to give 3a.
Compounds 3bt were synthesized by a similar procedure as described for compound 3a. For the separation of these compounds, the eluent of silica gel column chromatography consisted of appropriate mixtures of petroleum ether and ethyl acetate.

3.3. Spectral Data

(E)-3-Hydroxy-3-(2-oxo-4-phenylbut-3-en-1-yl)indolin-2-one (3a). Yield 98%; White solid; m.p. 159–160 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.23 (d, J = 16.0 Hz, 1H), 3.65 (d, J = 16.0 Hz, 1H), 6.05 (s, 1H), 6.74–6.80 (m, 2H), 6.88 (t, J = 8.0 Hz, 1H), 7.16 (t, J = 8.0 Hz, 1H), 7.28 (d, J = 8.0 Hz, 1H), 7.42–7.43 (m, 3H), 7.55 (d, J = 16.4 Hz, 1H), 7.67 (m, 2H), 10.24 (s, 1H); 13C-NMR (100 MHz, DMSO): δ 47.6, 73.1, 109.4, 121.1, 123.7, 126.4, 128.4, 128.9, 130.5, 131.5, 134.3, 142.5, 142.7, 178.2, 196.2; MS: m/z = 316 [M+Na]+.
(E)-3-Hydroxy-3-(4-(4-methoxyphenyl)-2-oxobut-3-en-1-yl)indolin-2-one (3b). Yield 95%; White solid; m.p. 167–168 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.20 (d, J = 16.4 Hz, 1H), 3.63 (d, J = 16.4 Hz, 1H), 3.80 (s, 3H), 6.04 (s, 1H), 6.62 (d, J = 16.4 Hz, 1H), 6.78 (d, J = 7.6 Hz, 1H), 6.88 (t, J = 7.6 Hz, 1H), 6.98 (t, J = 8.4 Hz, 2H), 7.16 (t, J = 7.6 Hz, 1H), 7.27 (d, J = 7.2 Hz, 1H), 7.51 (d, J = 16.4 Hz, 1H), 7.62 (d, J = 8.4 Hz, 2H), 10.23 (s, 1H); 13C-NMR (100 MHz, DMSO): δ 47.4, 55.3, 73.1, 109.3, 114.4, 121.1, 123.7, 124.1, 126.8, 128.9, 130.3, 131.5, 142.5, 142.7, 161.2, 178.3, 196.0; MS: m/z = 346 [M+Na]+.
(E)-3-(4-(4-Fluorophenyl)-2-oxobut-3-en-1-yl)-3-hydroxyindolin-2-one (3c). Yield 87%; White solid; m.p. 177–178 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.23 (d, J = 16.4 Hz, 1H), 3.66 (d, J = 16.4 Hz, 1H), 6.07 (s, 1H), 6.72 (d, J = 16.4 Hz, 1H), 6.79 (d, J = 7.6 Hz, 1H), 6.88 (t, J = 7.6 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 7.24–7.29 (m, 3H), 7.56 (d, J = 16.4 Hz, 1H), 7.74 (m, 2H), 10.26 (s, 1H); 13C-NMR (100 MHz, DMSO): δ = 47.6, 73.1, 109.4, 115.9 (d, J = 22 Hz), 121.1, 123.7, 126.3, 128.9, 130.8 (d, J = 8 Hz), 130.9 (d, J = 3 Hz), 131.5, 141.4, 142.7, 163.3 (d, J = 248 Hz), 178.2, 196.2; MS: m/z = 334 [M+Na].
(E)-3-(4-(4-Chlorophenyl)-2-oxobut-3-en-1-yl)-3-hydroxyindolin-2-one (3d). Yield 80%; White solid; m.p. 196–197 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.23 (d, J = 16.4 Hz, 1H), 3.65 (d, J = 16.4 Hz, 1H), 6.07 (s, 1H), 6.77 (m, 2H), 6.88 (t, J = 7.6 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 7.27 (d, J = 7.2 Hz, 1H), 7.51 (m, 3H), 7.70 (d, J =8.4 Hz, 2H), 10.25 (s, 1H);13C-NMR (100 MHz, DMSO): δ 47.7, 73.1, 109.4, 121.1, 123.7, 127.0, 129.0, 130.1, 131.4, 133.3, 135.0, 141.1, 142.6, 178.2, 196.2; MS: m/z = 350 [M+Na].
(E)-3-(4-(4-Bromophenyl)-2-oxobut-3-en-1-yl)-3-hydroxyindolin-2-one (3e). Yield 82%; White solid; m.p. 205–206 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.22 (d, J = 16.4 Hz, 1H), 3.64 (d, J = 16.4 Hz, 1H), 6.05 (s, 1H), 6.79 (m, 2H), 6.88 (t, J = 7.6 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 7.27 (d, J = 7.2 Hz, 1H), 7.52 (d, J = 16.0 Hz, 1H), 7.62 (s, 4H), 10.23 (s, 1H); 13C-NMR (100 MHz, DMSO): δ = 47.7, 73.1, 109.4, 121.1, 123.7, 123.8, 127.1, 128.9, 130.3, 131.4, 131.9, 133.6, 141.1, 142.6, 178.2, 196.2; MS: m/z = 394 [M+Na].
(E)-3-Hydroxy-3-(4-(4-nitrophenyl)-2-oxobut-3-en-1-yl)indolin-2-one (3f). Yield 75%; White solid; m.p. 195–196 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.25 (d, J = 16.4 Hz, 1H), 3.68 (d, J = 16.4 Hz, 1H), 6.09 (s, 1H), 6.76 (d, J = 7.6 Hz, 1H), 6.89 (t, J = 7.6 Hz, 1H), 6.95 (d, J = 16.4 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 7.28 (d, J =7.2 Hz, 1H), 7.63 (d, J = 16.4 Hz, 1H), 7.94 (d, J =8.8 Hz, 2H), 8.25 (d, J = 8.8 Hz, 2H), 10.27 (s, 1H); 13C-NMR (100 MHz, DMSO): δ = 47.9, 73.1, 109.4, 121.2, 123.8, 124.0, 129.0, 129.4, 129.9, 131.3 139.7, 140.9, 142.6, 148.0, 178.1, 196.3; MS: m/z = 361 [M+Na].
(E)-3-Hydroxy-3-(2-oxo-4-(3-(trifluoromethyl)phenyl)but-3-en-1-yl)indolin-2-one (3g). Yield 86%; White solid; m.p. 114–115 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.23 (d, J = 16.4 Hz, 1H), 3.65 (d, J = 16.4 Hz, 1H), 6.06 (s, 1H), 6.78 (d, J = 7.6 Hz, 1H), 6.88 (m, 2H), 7.16 (td, J = 7.6 Hz, J = 1.2 Hz, 1H), 7.27 (d, J = 7.6 Hz, 1H), 7.65 (m, 2H), 7.76 (d, J =7.6 Hz, 1H), 7.97 (d, J =8.0 Hz, 1H), 8.05 (s, 1H), 10.24 (s, 1H); 13C-NMR (100 MHz, DMSO): δ 47.9, 73.1, 109.4, 121.1, 123.8, 123.9 (q, J = 271 Hz), 124.9 (q, J = 14 Hz), 126.6 (q, J = 4 Hz), 128.2, 129.0, 129.6, 130.0, 131.4, 132.0, 135.6, 140.5, 142.6, 178.1, 196.2; MS: m/z = 384 [M+Na].
(E)-3-(4-(3-Bromophenyl)-2-oxobut-3-en-1-yl)-3-hydroxyindolin-2-one (3h). Yield 85%; White solid; m.p. 173–174 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.23 (d, J = 16.4 Hz, 1H), 3.65 (d, J = 16.4 Hz, 1H), 6.08 (s, 1H), 6.78–6.90 (m, 3H), 7.17 (t, J = 7.2 Hz, 1H), 7.27 (d, J = 6.8 Hz, 1H), 7.37 (t, J = 7.6 Hz, 1H), 7.50 (d, J =16.4 Hz, 1H), 7.61 (d, J = 7.2 Hz, 1H), 7.67 (d, J = 7.2 Hz, 1H), 7.91 (s, 1H), 10.26 (s, 1H); 13C-NMR (100 MHz, DMSO): δ 47.8, 73.1, 109.4, 121.1, 122.3, 123.7, 127.4, 127.7, 129.0, 130.8, 131.0, 131.4, 132.9, 136.9, 140.7, 142.6, 178.2, 196.2; MS: m/z = 394 [M+Na].
(E)-3-(4-(3-Chlorophenyl)-2-oxobut-3-en-1-yl)-3-hydroxyindolin-2-one (3i). Yield 82%; White solid; m.p. 150–151 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.22 (d, J = 16.4 Hz, 1H), 3.65 (d, J = 16.4 Hz, 1H), 6.06 (s, 1H), 6.79 (d, J = 7.6 Hz, 1H), 6.84 (d, J = 16.4 Hz, 1H), 6.89 (d, J = 7.6 Hz, 1H), 7.16 (td, J = 7.6 Hz, J = 0.8 Hz, 1H), 7.27 (d, J = 7.2 Hz, 1H), 7.42–7.53 (m, 3H), 7.63 (d, J = 7.2 Hz, 1H), 7.77 (s, 1H), 10.24 (s, 1H); 13C-NMR (100 MHz, DMSO): δ 47.8, 73.1, 109.4, 121.1, 123.7, 127.0, 127.8, 127.9, 129.0, 130.0, 130.7, 131.4, 133.7, 136.6, 140.7, 142.6, 178.1, 196.2; MS: m/z = 350 [M+Na].
(E)-3-Hydroxy-3-(4-(3-methoxyphenyl)-2-oxobut-3-en-1-yl)indolin-2-one (3j). Yield 96%; White solid; m.p. 158–159 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.21 (d, J = 16.0 Hz, 1H), 3.64 (d, J = 16.4 Hz, 1H), 3.78 (s, 3H), 6.05 (s, 1H), 6.75–6.79 (m, 2H), 6.88 (t, J = 7.6 Hz, 1H), 6.99 (d, J = 6.8 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 7.23–7.28 (m, 3H), 7.33 (t, J = 8.0 Hz, 1H), 7.51 (d, J = 16.0 Hz, 1H), 10.23 (s, 1H); 13C-NMR (100 MHz, DMSO): δ47.6, 55.2, 73.1, 109.4, 113.1, 116.6, 121.0, 121.1, 123.7, 126.7, 128.9, 129.9, 131.5, 135.7, 142.5, 142.7, 159.6, 178.2, 196.3; MS: m/z = 346 [M+Na].
(E)-3-(4-(2-Fluorophenyl)-2-oxobut-3-en-1-yl)-3-hydroxyindolin-2-one (3k). Yield 92%; White solid; m.p. 155–156 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.24 (d, J = 16.4 Hz, 1H), 3.63 (d, J = 16.4 Hz, 1H), 6.09 (s, 1H), 6.79 (d, J = 7.6 Hz, 1H), 6.84–6.90 (m, 2H), 7.14–7.18 (m, 1H), 7.23–7.30 (m, 3H), 7.45–7.48 (m, 1H), 7.53 (d, J = 16.4 Hz, 1H), 7.78 (t, J = 7.2 Hz, 1H), 10.27 (s, 1H); 13C-NMR (100 MHz, DMSO): δ = 48.1, 73.1, 109.4, 116.1(d, J = 22 Hz), 121.2, 121.8, 121.9, 123.8, 125.0 (d, J = 3 Hz), 128.4 (d, J = 5 Hz), 129.0, 129.2, 131.4, 132.5 (d, J = 9 Hz), 133.9 (d, J = 3 Hz), 142.6, 160.8 (d, J = 250 Hz), 178.2; MS: m/z = 334 [M+Na].
(E)-3-(4-(3,4-Dichlorophenyl)-2-oxobut-3-en-1-yl)-3-hydroxyindolin-2-one (3l). Yield 73%; White solid; m.p. 166–167 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.22 (d, J = 16.4 Hz, 1H), 3.63 (d, J = 16.4 Hz, 1H), 6.07 (s, 1H), 6.78 (d, J = 7.6 Hz, 1H), 6.88 (m, 2H), 7.16 (t, J = 7.6 Hz, 1H), 7.27 (d, J = 7.6 Hz, 1H), 7.51 (d, J = 16.0 Hz, 1H), 7.67–7.69 (m, 2H), 7.99 (s, 1H), 10.25 (s, 1H); 13C-NMR (100 MHz, DMSO): δ47.8, 73.0, 109.4, 121.1, 123.7, 128.2, 128.3, 129.0, 130.1, 131.0, 131.4, 131.7, 132.6, 135.3, 139.7, 142.6, 178.1, 196.2; MS: m/z = 384 [M+Na].
(E)-3-Hydroxy-3-(4-(naphthalen-2-yl)-2-oxobut-3-en-1-yl)indolin-2-one (3m). Yield 81%; White solid; m.p. 172–173 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.28 (d, J = 16.0 Hz, 1H), 3.71 (d, J = 16.4 Hz, 1H), 6.09 (s, 1H), 6.81 (d, J = 7.6 Hz, 1H), 6.88–6.93 (m, 2H), 7.17 (t, J = 7.6 Hz, 1H), 7.31 (d, J = 7.2 Hz, 1H), 7.57 (m, 2H), 7.70 (d, J = 16.4 Hz, 1H), 7.82 (d, J = 8.4 Hz, 1H), 7.94 (m, 3H), 8.19 (s, 1H), 10.27 (s, 1H); 13C-NMR (100 MHz, DMSO): δ 47.8, 73.2, 109.4, 121.1, 123.8, 123.9, 126.6, 126.8, 127.4, 127.7, 128.4, 128.5, 128.9, 130.2, 131.5, 131.9, 132.9, 133.8, 142.4, 142.7, 178.2, 196.2; MS: m/z = 344 [M+H].
(E)-3-(4-(Furan-2-yl)-2-oxobut-3-en-1-yl)-3-hydroxyindolin-2-one (3n). Yield 88%; White solid; m.p. 151–152 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.15 (d, J = 16.0 Hz, 1H), 3.55 (d, J = 16.0 Hz, 1H), 6.04 (s, 1H), 6.47 (d, J = 15.6 Hz, 1H), 6.64 (s, 1H), 6.77 (d, J = 7.2 Hz, 1H), 6.88 (m, 1H), 6.95 (m, 1H), 7.16 (m, 1H), 7.25 (m, 1H), 7.33 (d, J = 16.0 Hz, 1H), 7.85 (s, 1H), 10.23 (s, 1H); 13C-NMR (100 MHz, DMSO): δ 47.7, 73.1, 109.4, 113.0, 116.8, 121.1, 123.1, 123.8, 128.9, 129.0, 131.4, 142.6, 146.1, 150.4, 178.2, 195.6; MS: m/z = 306 [M+Na].
(E)-3-Hydroxy-3-(2-oxohept-3-en-1-yl)indolin-2-one (3o). Yield 67%; oil; 1H-NMR (400 MHz, TMS, DMSO): δ 0.91 (t, J = 4.0 Hz, 3H), 1.40 (m, 2H), 2.16 (m, 2H), 3.12 (d, J = 16.0 Hz, 1H), 3.52 (d, J = 16.0 Hz, 1H), 5.96–6.04 (m, 2H), 6.77 (d, J = 7.6 Hz, 1H), 6.87 (t, J = 7.6 Hz, 1H), 7.04 (d, J = 16.0 Hz, 1H), 7.15 (t, J = 7.6 Hz, 1H), 7.23 (t, J = 7.6 Hz, 1H), 10.19 (s, 1H); 13C-NMR (100 MHz, DMSO): δ 13.7, 21.9, 30.1, 47.7, 73.1, 109.3, 121.1, 123.6, 128.8, 131.5, 139.1, 142.6, 146.2, 178.2, 196.2; MS: m/z = 282 [M+Na].
(E)-1-Benzyl-3-hydroxy-3-(2-oxo-4-phenylbut-3-en-1-yl)indolin-2-one (3p). Yield 99%; White solid; m.p. 57–58 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.40 (d, J = 16.8 Hz, 1H), 3.83 (d, J = 16.8 Hz, 1H), 4.85 (d, J = 8.0 Hz, 1H), 4.93 (d, J = 8.0 Hz, 1H), 6.30 (s, 1H), 6.73–6.81 (m, 2H), 6.95 (t, J = 7.2 Hz, 1H), 7.16 (t, J = 7.2 Hz, 1H), 7.27 (d, J = 7.2 Hz, 1H), 7.33–7.47 (m, 8H), 7.60 (d, J = 16.0 Hz, 1H), 7.67 (m, 2H); 13C-NMR (100 MHz, DMSO): δ 42.7, 47.7, 72.8, 108.9, 122.0, 123.5, 126.2, 127.2, 128.4, 128.5, 128.9, 129.0, 130.6, 130.9, 134.2, 136.4, 142.9, 143.2, 176.8, 196.3; MS: m/z = 384 [M+H].
(E)-3-Hydroxy-5-methyl-3-(2-oxo-4-phenylbut-3-en-1-yl)indolin-2-one (3q). Yield 60%; White solid; m.p. 136–137 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 2.19 (s, 3H), 3.23 (d, J = 16.4 Hz, 1H), 3.62 (d, J = 16.4 Hz, 1H), 6.02 (s, 1H), 6.68 (d, J =8.0 Hz, 1H), 6.76 (d, J = 16.0 Hz, 1H), 6.96 (d, J = 7.6 Hz, 1H), 7.10 (s, 1H), 7.43 (m, 3H), 7.53 (d, J = 16.0 Hz, 1H), 7.66 (m, 2H), 10.15 (s, 1H); 13C-NMR (100 MHz, DMSO): δ = 20.6, 47.7, 73.2, 109.1, 124.4, 126.4, 128.4, 128.9, 129.1, 129.8, 130.5, 131.5, 134.3, 140.2, 142.5, 178.2, 196.2; MS: m/z = 330 [M+Na].
(E)-5-Bromo-3-hydroxy-3-(2-oxo-4-phenylbut-3-en-1-yl)indolin-2-one (3r). Yield 99%; White solid; m.p. 201–202 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.30 (d, J = 16.8 Hz, 1H), 3.75 (d, J = 16.8 Hz, 1H), 6.20 (s, 1H), 6.74–6.79 (m, 2H), 7.34–7.59 (m, 6H), 7.67 (m, 2H), 10.40 (s, 1H); 13C-NMR (100 MHz, DMSO): δ = 47.4, 73.1, 111.4, 112.9, 126.2, 126.7, 128.5, 128.9, 130.6, 131.5, 134.1, 134.2, 142.1, 142.8, 177.8, 196.3; MS: m/z = 394 [M+Na].
(E)-6-Chloro-3-hydroxy-3-(2-oxo-4-phenylbut-3-en-1-yl)indolin-2-one (3s). Yield 93%; Yellow solid; m.p. 188–189 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.27 (d, J = 16.8 Hz, 1H), 3.70 (d, J = 16.8 Hz, 1H), 6.15 (s, 1H), 6.75 (d, J = 16.0 Hz, 1H), 6.79 (m, 1H), 6.93 (m, 1H), 7.29 (d, J = 8.0 Hz, 1H), 7.43 (m, 3H), 7.55 (d, J = 16.0 Hz, 1H), 7.67 (m, 2H), 10.41 (s, 1H); 13C-NMR (100 MHz, DMSO): δ = 47.4, 72.6, 109.4, 120.8, 125.1, 126.2, 128.5, 128.9, 130.5, 130.6, 133.1, 134.2, 142.8, 144.3, 178.2, 196.3; MS: m/z = 350 [M+Na].
(E)-4-Chloro-3-hydroxy-3-(2-oxo-4-phenylbut-3-en-1-yl)indolin-2-one (3t). Yield 92%; Yellow solid; m.p. 193–195 °C; 1H-NMR (400 MHz, TMS, DMSO): δ 3.25 (d, J = 16.8 Hz, 1H), 4.03 (d, J = 16.8 Hz, 1H), 6.22 (s, 1H), 6.76 (m, 2H), 6.86 (d, J = 8.4 Hz, 1H), 7.18 (t, J = 8.0 Hz, 1H), 7.43 (m, 3H), 7.58 (d, J = 16.4 Hz, 1H), 7.68 (m, 2H), 10.50 (s, 1H); 13C-NMR (100 MHz, DMSO): δ = 45.8, 73.8, 108.5, 122.0, 125.8, 127.5, 128.5, 128.9, 129.8, 130.6, 134.1, 143.0, 145.0, 177.4, 196.2; MS: m/z = 350 [M+Na].

4. Conclusions

In conclusion, we have developed an efficient approach for the direct preparation of 3-substituted-3-hydroxy-2-oxindoles via an aldol reaction of α,β-unsaturated ketones and isatins using arginine as an organocatalyst. A range of 3-substituted-3-hydroxy-2-oxindoles were obtained in moderate to high yields (up to 99%). The formation of 3-substituted-3-hydroxy-2-oxindole (3a) was confirmed by X-ray crystallography. The reaction is simple, the catalyst easily availability, and the procedure convenient with mild reaction conditions, which make it useful. The possible reaction mechanism reveals that the reaction proceeds via a double action process. The 3-substituted-3-hydroxy-2-oxindoles with an additional enone moiety and provide a chance for finding new or improved biological activities and further elaboration of the products. Further study on the antibacterial and antitumor activities of these compounds is underway.

Acknowledgments

We appreciate the financial support of National Natural Science Foundation of China (No. 81202403) and Youth Foundation of Sichuan University (Nos. 2012SCU11090 and 2011SCU11005). We also thank Sichuan University Analytical & Testing Center for the NMR analysis.

Conflicts of Interest

The authors declare no conflict of interest.

References and Notes

  1. Peddibhotla, S. 3-Substituted-3-hydroxy-2-oxindole, an emerging new scaffold for drug discovery with potential anti-cancer and other biological activities. Curr. Bioact. Compd. 2009, 5, 20–38. [Google Scholar] [CrossRef]
  2. Zhang, H.P.; Kamano, Y.; Ichihara, Y.; Kizu, H.; Komiyama, K.; ltokawa, H.; Pettit, G.R. Isolation and structure of convolutamydines B–D from marine bryozoan Amathia convoluta. Tetrahedron 1995, 51, 5523–5528. [Google Scholar] [CrossRef]
  3. Khuzhaev, V.U.; Zhalolov, I.; Turguniv, K.K.; Tashkhodzhaev, B.; Levkovich, M.G.; Arpova, S.F.; Shashkov, A.S. Alkaloids from Arundo donax. XVII. structure of the dimeric indole alkaloid arundaphine. Chem. Nat. Compd. 2004, 40, 269–272. [Google Scholar] [CrossRef]
  4. Rasmussen, H.B.; MacLeod, J.K. Total synthesis of donaxaridine. J. Nat. Prod. 1997, 60, 1152–1154. [Google Scholar] [CrossRef]
  5. Suchý, M.; Kutschy, P.; Monde, K.; Goto, H.; Harada, N.; Takasugi, M.; Dzurilla, M.; Balentová, E. Synthesis, absolute configuration, and enantiomeric dnrichment of a ruciferous oxindole phytoalexin, (S)-(−)-Spirobrassinin, and its oxazoline analog. J. Org. Chem. 2001, 66, 3940–3947. [Google Scholar] [CrossRef]
  6. Tang, Y.Q.; Sattler, I.; Thiericke, R.; Grabley, S.; Feng, X.Z. Maremycins C and D, new diketopiperazines, and maremycins E and F, novel polycyclic spiro-Indole metabolites isolated from Streptomyces sp. Eur. J. Org. Chem. 2001, 2001, 261–267. [Google Scholar]
  7. Kagata, T.; Saito, S.; Shigemori, H.; Ohsaki, A.; Ishiyama, H.; Kubota, T.; Kobayashi, J. Paratunamides A–D, oxindole alkaloids from Cinnamodendron axillare. J. Nat. Prod. 2006, 69, 1517–1521. [Google Scholar] [CrossRef]
  8. Suzuki, H.; Morita, H.; Shiro, M.; Kobayashi, J. Celogentin K, a new cyclic peptide from the seeds of Celosia argentea and X-ray structure of moroidin. Tetrahedron 2004, 60, 2489–2495. [Google Scholar] [CrossRef]
  9. Koguchi, Y.; Kohno, J.; Nishio, M.; Takahashi, K.; Okuda, T.; Ohnuki, T.; Komatsubara, S. TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities. J. Antibiot. 2000, 53, 105–109. [Google Scholar] [CrossRef]
  10. Carle, J.S.; Christophersen, C. Marine alkaloids. 3. Bromo-substituted alkaloids from the marine bryozoan Flustra foliacea, flustramine C and flustraminol A and B. J. Org. Chem. 1981, 46, 3440–3443. [Google Scholar] [CrossRef]
  11. Jimenez, J.I.; Huber, U.; Moore, R.E.; Patterson, G.M.L. Oxidized Welwitindolinones from Terrestrial Fischerella spp. J. Nat. Prod. 1999, 62, 569–572. [Google Scholar] [CrossRef]
  12. Kitajima, M.; Mori, I.; Arai, K.; Kogure, N.; Takayama, H. Two new tryptamine-derived alkaloids from Chimonanthus praecox f. concolor. Tetrahedron Lett. 2006, 47, 3199–3202. [Google Scholar] [CrossRef]
  13. Lee, S.; Hartwig, J.F. Improved catalysts for the palladium-catalyzed synthesis of oxindoles by amide α-arylation. rate acceleration, use of aryl chloride substrates, and a new carbene ligand for asymmetric transformations. J. Org. Chem. 2001, 66, 3402–3415. [Google Scholar] [CrossRef]
  14. Shibata, N.; Tarui, T.; Doi, Y.; Kirk, K.L. Synthesis of fluorogypsetin and fluorobrevianamide E by a novel fluorination-cyclization of cyclo-L-Trp-L-AAs. Angew. Chem. Int. Ed. 2001, 40, 4461–4463. [Google Scholar] [CrossRef]
  15. Shibata, N.; Suzuki, E.; Asahi, T.; Shiro, M. Enantioselective fluorination mediated by cinchona alkaloid derivatives/selectfluor combinations: Reaction scope and structural information for N-fluorocinchona alkaloids. J. Am. Chem. Soc. 2001, 123, 7001–7009. [Google Scholar] [CrossRef]
  16. Funabashi, K.; Jachmann, M.; Kanai, M.; Shibasaki, M. Multicenter strategy for the development of catalytic enantioselective nucleophilic alkylation of ketones: Me2Zn addition to α-ketoesters. Angew. Chem. Int. Ed. 2003, 42, 5489–5492. [Google Scholar] [CrossRef]
  17. Hamashima, Y.; Suzuki, T.; Takano, H.; Shimura, Y.; Sodeoka, M. Catalytic enantioselective fluorination of oxindoles. J. Am. Chem. Soc. 2005, 127, 10164–10165. [Google Scholar] [CrossRef]
  18. Shintani, R.; Inoue, M.; Hayashi, T. Rhodium-catalyzed asymmetric addition of aryl- and alkenylboronic acids to isatins. Angew. Chem. Int. Ed. 2006, 45, 3353–3356. [Google Scholar] [CrossRef]
  19. Nakamura, T.; Shirokawa, S.; Hosokawa, S.; Nakazaki, A.; Kobayashi, S. Enantioselective total synthesis of convolutamydines B and E. Org. Lett. 2006, 8, 677–679. [Google Scholar] [CrossRef]
  20. Guo, X.; Huang, H.X.; Yang, L.P.; Hu, W.H. Trapping of oxonium ylide with isatins: Efficient and stereoselective construction of adjacent quaternary carbon centers. Org. Lett. 2007, 9, 4721–4723. [Google Scholar] [CrossRef]
  21. Malkov, A.V.; Kabeshov, M.A.; Bella, M.; Kysilka, O.; Malyshev, D.A.; Pluháčková, K.; Kočovský, P. Vicinal amino alcohols as organocatalysts in asymmetric cross-aldol reaction of ketones: Application in the synthesis of convolutamydine A. Org. Lett. 2007, 9, 5473–5476. [Google Scholar] [CrossRef]
  22. Chen, J.R.; Liu, X.P.; Zhu, X.Y.; Li, L.; Qiao, Y.F.; Zhang, J.M.; Xiao, W.J. Organocatalytic asymmetric aldol reaction of ketones with isatins: Straightforward stereoselective synthesis of 3-alkyl-3-hydroxyindolin-2-ones. Tetrahedron 2007, 63, 10437–10444. [Google Scholar] [CrossRef]
  23. Angelici, G.; Corrêa, R.J.; Garden, S.J.; Tomasini, C. Water influences the enantioselectivity in the proline or prolinamide-catalyzed aldol addition of acetone to isatins. Tetrahedron Lett. 2009, 50, 814–817. [Google Scholar] [CrossRef]
  24. Hara, N.; Nakamura, S.; Shibata, N.; Toru, T. Enantioselective aldol reaction using recyclable montmorillonite-entrapped N-(2-thiophenesulfonyl) prolinamide. Adv. Synth. Catal. 2010, 352, 1621–1624. [Google Scholar] [CrossRef]
  25. Guo, Q.S.; Bhanushali, M.; Zhao, C.G. Quinidine Thiourea-catalyzed aldol reaction of unactivated ketones: Highly enantioselective synthesis of 3-alkyl-3-hydroxyindolin-2-ones. Angew. Chem. Int. Ed. 2010, 49, 9460–9464. [Google Scholar] [CrossRef]
  26. Raj, M.; Veerasamy, N.; Singh, V.K. Highly enantioselective synthesis of 3-cycloalkanone-3-hydroxy-2-oxindoles, potential anticonvulsants. Tetrahedron Lett. 2010, 51, 2157–2159. [Google Scholar] [CrossRef]
  27. Allu, S.; Molleti, N.; Panem, R.; Singh, V.K. Enantioselective organocatalytic aldol reaction of unactivated ketones with isatins. Tetrahedron Lett. 2011, 52, 4080–4083. [Google Scholar] [CrossRef]
  28. Kinsella, M.; Duggan, P.G.; Lennon, C.M. Screening of simple N-aryl and N-heteroaryl pyrrolidine amide organocatalysts for the enantioselective aldol reaction of acetone with isatin. Tetrahedron Asymmetry 2011, 22, 1423–1433. [Google Scholar] [CrossRef]
  29. Liu, G.G.; Zhao, H.; Lan, Y.B.; Wu, B.; Huang, X.F.; Chen, J.; Tao, J.C.; Wang, X.W. Asymmetric cross aldol addition of isatins with α,β-unsaturated ketones catalyzed by a bifunctional Brønsted acid–Brønsted base organocatalyst. Tetrahedron 2012, 68, 3843–3850. [Google Scholar] [CrossRef]
  30. Cui, H.L.; Tanaka, F. Catalytic enantioselective formal hetero-Diels-Alder reactions of enones with isatins to give spirooxindole tetrahydropyranones. Chem. Eur. J. 2013, 19, 6213–6216. [Google Scholar] [CrossRef]
  31. Beccalli, E.M.; Marchesini, A.; Pilati, T. Synthesis of the carbazole alkaloids hyellazole and 6-chlorohyellazole and related derivatives. J. Chem. Soc. Perkin Trans. 1994, 1, 579–587. [Google Scholar] [CrossRef]
  32. Peng, Y.Y.; Wang, Q.; He, J.Q.; Cheng, J.P. Arginine catalyzed direct aldol reactions in pure water: An environmentally friendly reaction system. Chin. J. Chem. 2008, 26, 1454–1460. [Google Scholar] [CrossRef]
  33. Ma, J.A. Recent developments in the catalytic asymmetric synthesis of α- and β-amino acids. Angew. Chem. Int. Ed. 2003, 42, 4290–4299. [Google Scholar] [CrossRef]
  34. Maruoka, K.; Ooi, T. Enantioselective amino acid synthesis by chiral phase-transfer catalysis. Chem. Rev. 2003, 103, 3013–3028. [Google Scholar] [CrossRef]
  35. Plaquevent, J.C.; Levillain, J.; Guillen, F.; Malhiac, C.; Gaumont, A.C. Ionic liquids: New targets and media for α-amino acid and peptide chemistry. Chem. Rev. 2008, 108, 5035–5060. [Google Scholar] [CrossRef]
  36. List, B.; Lerner, R.A.; Barbas, C.F., III. Proline-catalyzed direct asymmetric aldol reactions. J. Am. Chem. Soc. 2000, 122, 2395–2396. [Google Scholar] [CrossRef]
  37. List, B. Proline-catalyzed asymmetric reactions. Tetrahedron 2002, 58, 5573–5590. [Google Scholar] [CrossRef]
  38. Crystallographic data of 3a reported in this manuscript have been deposited with Cambridge Crystallographic Data Centre as supplementary publication No. CCDC-936278. Copies of the data can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge, CB21EZ, UK; fax: +441223 336033; or [email protected]).
  39. Kim, J.; Jung, S.; Park, S.; Park, S. Amino-acid-mediated epoxidation of α,β-unsaturated ketones by hydrogen peroxide in aqueous media. Tetahedron Lett. 2011, 52, 2866–2868. [Google Scholar] [CrossRef]
  40. Rahmati, A.; Vakili, K. l-Histidine and l-arginine promote Knoevenagel reaction in water. Amino Acids 2010, 39, 911–916. [Google Scholar]
  41. Yu, Z.P.; Liu, X.H.; Zhou, L.; Lin, L.L.; Feng, X.M. Bifunctional guanidine via an amino Amide skeleton for asymmetric michael reactions of β-ketoesters with nitroolefins: A concise synthesis of bicyclic β-amino acids. Angew. Chem. Int. Ed. 2009, 48, 5195–5198. [Google Scholar] [CrossRef]
  • Sample Availability: Samples of all the compounds are available from the authors.

Share and Cite

MDPI and ACS Style

Yan, T.; Wang, X.; Sun, H.; Liu, J.; Xie, Y. Facile Creation of 3-Substituted-3-Hydroxy-2-Oxindoles by Arginine-Catalyzed Aldol Reactions of α,β-Unsaturated Ketones with Isatins. Molecules 2013, 18, 14505-14518. https://doi.org/10.3390/molecules181214505

AMA Style

Yan T, Wang X, Sun H, Liu J, Xie Y. Facile Creation of 3-Substituted-3-Hydroxy-2-Oxindoles by Arginine-Catalyzed Aldol Reactions of α,β-Unsaturated Ketones with Isatins. Molecules. 2013; 18(12):14505-14518. https://doi.org/10.3390/molecules181214505

Chicago/Turabian Style

Yan, Tingting, Xiaoyan Wang, Hongbao Sun, Jie Liu, and Yongmei Xie. 2013. "Facile Creation of 3-Substituted-3-Hydroxy-2-Oxindoles by Arginine-Catalyzed Aldol Reactions of α,β-Unsaturated Ketones with Isatins" Molecules 18, no. 12: 14505-14518. https://doi.org/10.3390/molecules181214505

Article Metrics

Back to TopTop